Amicus Therapeutics to Announce Full-Year 2016 Financial Results and Corporate Updates on March 1, 2017
February 22 2017 - 5:36PM
Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company
at the forefront of therapies for rare and orphan diseases, today
announced a conference call and live audio webcast on Wednesday,
March 1, 2017 at 8:30 a.m. ET to discuss financial results for the
year ended December 31, 2016.
The call will be hosted by John F. Crowley,
Chairman and Chief Executive Officer. He will be joined on the call
by additional members of the Amicus management team. Interested
participants and investors may access the conference call by
dialing 877-303-5859 (U.S./Canada) or 678-224-7784
(international).
A live audio webcast can also be accessed via
the Investors section of the Amicus Therapeutics corporate website
at http://ir.amicusrx.com/, and will be archived for 30 days. Web
participants are encouraged to go to the website 15 minutes prior
to the start of the call to register, download, and install any
necessary software.
A telephonic replay of the call will be
available for seven days beginning at 11:30 a.m. ET on March 1,
2017. Access numbers for this replay are 855-859-2056 (U.S./Canada)
and 404-537-3406 (international); conference ID: 77299407.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq:FOLD) is a global
biotechnology company at the forefront of therapies for rare and
orphan diseases. The Company has a robust pipeline of advanced
therapies for a broad range of human genetic diseases. Amicus’ lead
programs in development include the small molecule pharmacological
chaperone migalastat as a monotherapy for Fabry disease, SD-101 for
Epidermolysis Bullosa (EB), as well as novel enzyme replacement
therapy (ERT) and biologic products for Fabry disease, Pompe
disease, and other rare and devastating diseases.
FOLD–G
CONTACTS:
Investors/Media:
Amicus Therapeutics
Sara Pellegrino
Senior Director, Investor Relations
spellegrino@amicusrx.com
(609) 662-5044
Media:
MWW PR
Sid Dinsay
sdinsay@mww.com
(646) 381-9017
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Apr 2024 to May 2024
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From May 2023 to May 2024